Verproside, the Most Active Ingredient in YPL-001 Isolated from Pseudolysimachion rotundum var. subintegrum, Decreases Inflammatory Response by Inhibiting PKCδ Activation in Human Lung Epithelial Cells

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease which causes breathing problems. YPL-001, consisting of six iridoids, has potent inhibitory efficacy against COPD. Although YPL-001 has completed clinical trial phase 2a as a natural drug for COPD treatment, the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Eun Sol, Ryu, Hyung Won, Kim, Mun-Ock, Lee, Jae-Won, Song, Yu Na, Park, Ji-Yoon, Kim, Doo-Young, Ro, Hyunju, Lee, Jinhyuk, Kim, Tae-Don, Hong, Sung-Tae, Lee, Su Ui, Oh, Sei-Ryang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138391/
https://www.ncbi.nlm.nih.gov/pubmed/37108390
http://dx.doi.org/10.3390/ijms24087229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138391/
https://www.ncbi.nlm.nih.gov/pubmed/37108390
http://dx.doi.org/10.3390/ijms24087229

Ejemplares similares